Fulgent Genetics (FLGT) Short-term Investments (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Short-term Investments for 10 consecutive years, with $285.9 million as the latest value for Q4 2025.
- Quarterly Short-term Investments rose 40.86% to $285.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $285.9 million through Dec 2025, up 40.86% year-over-year, with the annual reading at $285.9 million for FY2025, 40.86% up from the prior year.
- Short-term Investments hit $285.9 million in Q4 2025 for Fulgent Genetics, up from $258.2 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $446.7 million in Q4 2022 to a low of $155.0 million in Q3 2024.
- Historically, Short-term Investments has averaged $297.3 million across 5 years, with a median of $270.8 million in 2021.
- Biggest five-year swings in Short-term Investments: soared 1429.02% in 2021 and later tumbled 59.6% in 2024.
- Year by year, Short-term Investments stood at $285.6 million in 2021, then skyrocketed by 56.41% to $446.7 million in 2022, then dropped by 26.87% to $326.7 million in 2023, then tumbled by 37.87% to $203.0 million in 2024, then soared by 40.86% to $285.9 million in 2025.
- Business Quant data shows Short-term Investments for FLGT at $285.9 million in Q4 2025, $258.2 million in Q3 2025, and $205.0 million in Q2 2025.